Assessment of tumor response to neoadjuvant chemotherapy in patients with breast cancer using MRI and FDG-PET/CT-RECIST 1.1 vs. PERCIST 1.0

Therapeutic response to neoadjuvant chemotherapy (NAC) for breast cancer based on Positron Emission Tomography Response Criteria in Solid Tumors (PERCIST) 1.0 with FDG-PET/CT measurements was evaluated, and the results compared to those obtained with currently widely used Response Evaluation Criteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitajima, Kazuhiro, Miyoshi, Yasuo, Yamano, Toshiko, Odawara, Soichi, Higuchi, Tomoko, Yamakado, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995733/
https://www.ncbi.nlm.nih.gov/pubmed/29915436
http://dx.doi.org/10.18999/nagjms.80.2.183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995733/
https://www.ncbi.nlm.nih.gov/pubmed/29915436
http://dx.doi.org/10.18999/nagjms.80.2.183

Ejemplares similares